Since sHLA-G also contributes to anti-angiogenesis by inducing apoptosis of endothelial cells (Fons et al. 2006), we therefore speculated that the angiogenesis switch in MM might require HIF-1-mediated regulation of VEGF and sHLA-G, particularly under hypoxia. The gene discussed is HIF1A; the disease is Miyoshi myopathy.